First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX) Stock Price, Quote & AI Analysis

Live TRAX stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for First Tracks Biotherapeutics, Inc. Ordinary Shares.

TradeVae provides AI-driven analysis and real-time market intelligence for First Tracks Biotherapeutics, Inc. Ordinary Shares (TRAX), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

T
TRAX
First Tracks Biotherapeutics, Inc. Ordinary Shares
real-time
$0.00 +0.00 (+0.00%)
Open
17.440000
High
21.660000
Low
17.440000
Volume
572,361
VWAP
-
Market Cap
$628,954,022.10
52W Range
$14.79 - $26.80
P/E Ratio
-
EPS
-
Debt/Equity
-
EV/EBITDA
-
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

First Tracks Biotherapeutics, Inc. Ordinary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

First Tracks Biotherapeutics, Inc. Ordinary Shares Overview

Company information

Company Overview

First Tracks Biotherapeutics, Inc. engages in the research and development of immunology therapeutics for autoimmune and inflammatory diseases. It focuses on clinical-stage programs for rosnilimab, ANB033 and ANB101. The company is headquartered in San Diego, CA.

Company Details
Market Cap
$694.41M
Shares Outstanding
34,634,032
Weighted Shares Outstanding
34,748,841
CEO
Daniel R. Faga
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

First Tracks Biotherapeutics, Inc. Ordinary Shares Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...